I lead commercial strategy at Impatient Health, where I use the fundamentals of design-thinking cultivated in advanced materials engineering to create innovative ways to connect the industry and find new and exciting companies to partner with.
The pharmaceutical industry must become more agile in its pursuit of better outcomes and patient-centricity. Change is accelerating like never before. Impatient health is facilitating this change with our unique network and position of responsibility in an industry where connecting people is fundamental to driving innovation. We can radically cultivate patient-centric innovation, empowering opportunities with superior relationships. We are making a difference.